Atyr Pharma vs Clene
Atyr Pharma and Clene are similar in size: $190,000 and $200,000 of revenue in their latest fiscal years. Atyr Pharma grew faster (-19.1% against -41.5%). Clene kept more of each dollar of sales as profit: a net margin of -13086.5% against -39009.5%.
| Latest fiscal year | Atyr PharmaATYR, 2025 | CleneCLNN, 2025 |
|---|---|---|
| Revenue | $190,000 | $200,000 |
| Revenue growth | -19.1% | -41.5% |
| Net income | −$74.1m | −$26.2m |
| Operating margin | -40856.3% | — |
| Net margin | -39009.5% | -13086.5% |
| Return on equity | -107.8% | — |
| Free cash flow | −$62.1m | −$18.6m |
| Cash | $10.7m | $5.2m |
| Total debt | $0 | $17.8m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 58 | 79 |
| Market value | $622m | $47.9m |
| Price vs our value range | — | — |
| Moat score | — | 12 (Weak) |
| Insider trades, 12 months | 1 buys, 3 sales | 1 buys, 62 sales |